GRUPPO NUTRITION INC. – Trademark Portfolio

Entity Type: 03

GRUPPO NUTRITION INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include DEEPLEAF. The owner is based in WINDSOR, ONTARIO.

1540 MCDOUGALL STREET

WINDSOR, ONTARIO N8X 3N2 , CA

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GRUPPO NUTRITION INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (2 filings)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does GRUPPO NUTRITION INC. have?

GRUPPO NUTRITION INC. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending.

What trademark classes does GRUPPO NUTRITION INC. file in?

GRUPPO NUTRITION INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are GRUPPO NUTRITION INC.'s most well-known trademarks?

GRUPPO NUTRITION INC.'s registered trademark portfolio includes well-known marks such as DEEPLEAF. These are among 1 currently registered trademark in the portfolio.

What is GRUPPO NUTRITION INC.'s trademark registration success rate?

GRUPPO NUTRITION INC. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 2 applications are pending review.